2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Endocrine Related Cancer
Endocrine-related cancers arise from glands that produce hormones, such as the thyroid, adrenal, and pituitary glands. These cancers often exhibit unique characteristics due to the role hormones play in cell growth and regulation. Research in this field aims to understand the intricate interplay between hormones and cancer development, seeking targeted treatments that disrupt cancerous cell growth while sparing healthy tissue. Advances in molecular biology have unveiled specific genetic mutations driving endocrine-related cancers, paving the way for personalized therapies tailored to individual patients. Additionally, emerging immunotherapy approaches hold promise in bolstering the body's immune response against these cancers. Through interdisciplinary collaboration and innovative technologies, scientists strive to improve early detection methods and develop more effective treatment strategies, ultimately enhancing outcomes for patients battling endocrine-related cancers.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China